These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11200823)

  • 21. Classical pathway complement activation in Kawasaki syndrome.
    Kohsaka T; Abe J; Asahina T; Kobayashi N
    J Allergy Clin Immunol; 1994 Feb; 93(2):520-5. PubMed ID: 8120278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet activity and antibody titers after exposure to streptokinase or streptococcal infection.
    Courval M; Palisaitis DA; Diodati JG; Lesperance B; Pharand C
    Thromb Res; 2003; 111(4-5):243-9. PubMed ID: 14693171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does intravenous streptokinase therapy facilitate the formation of anti-heart antibodies in acute myocardial infarction?
    Scolozzi R; Boccafogli A; Vicentini L; Masotti M; Baraldi A; Pradella A; Baggioni GF; Camerani A; Boniotti A
    Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):297-300. PubMed ID: 2640051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can anti-streptokinase antibody predict myocardial infarction outcomes after streptokinase treatment?
    Sadeghi M; Golabchi A; Haghani P; Gharipour M; Naderi GA; Sarrafzadegan N
    J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S31-4. PubMed ID: 22768454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
    Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
    Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G; Makinde VA; Vergani D; Isenberg DA
    Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement activation in patients with acute myocardial infarction treated with streptokinase.
    Oren S; Maslovsky I; Schlesinger M; Reisin L
    Am J Med Sci; 1998 Jan; 315(1):24-9. PubMed ID: 9427571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralising antibodies after streptokinase treatment for myocardial infarction: a persisting puzzle.
    McGrath K; Hogan C; Hunt D; O'Malley C; Green N; Dauer R; Dalli A
    Br Heart J; 1995 Aug; 74(2):122-3. PubMed ID: 7546988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-streptokinase titers and response to streptokinase treatment in Pakistani patients.
    Kazmi KA; Perwaiz Iqbal M; Rahbar A; Mehboobali N
    Int J Cardiol; 2002 Mar; 82(3):247-51. PubMed ID: 11911912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
    Li J; An L; Zhang Z
    Clin Exp Rheumatol; 2014; 32(1):48-53. PubMed ID: 23981509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
    Senaldi G; Peakman M; McManus T; Davies ET; Tee DE; Vergani D
    J Infect Dis; 1990 Dec; 162(6):1227-32. PubMed ID: 1977807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overt and subclinical reactions to streptokinase in acute myocardial infarction.
    Lynch M; Pentecost BL; Littler WA; Stockley RA
    Am J Cardiol; 1994 Nov; 74(9):849-52. PubMed ID: 7977112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping of the antigenic regions of streptokinase in humans after streptokinase therapy.
    Torréns I; Reyes O; Ojalvo AG; Seralena A; Chinea G; Cruz LJ; de la Fuente J
    Biochem Biophys Res Commun; 1999 May; 259(1):162-8. PubMed ID: 10334933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Streptokinase immunogenicity in thrombolytic therapy for acute myocardial infarction.
    Rosenschein U; Lenz R; Radnay J; Ben Tovim T; Rozenszajn LA
    Isr J Med Sci; 1991 Oct; 27(10):541-5. PubMed ID: 1955306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypersensitivity reactions to streptokinase in patients with high pre-treatment antistreptokinase antibody and neutralisation titres.
    Lee HS; Yule S; McKenzie A; Cross S; Reid T; Davidson R; Jennings K
    Eur Heart J; 1993 Dec; 14(12):1640-3. PubMed ID: 8131761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical usefulness of a functional test of neutralising streptokinase antibodies for the prediction of the thrombolytic effect of streptokinase in acute myocardial infarction.
    Gill S; Kristensen SR; Haastrup B; Haghfelt T
    Cardiology; 2003; 100(1):36-40. PubMed ID: 12975544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiling the immune responses of human patients treated with recombinant streptokinase after myocardial infarct.
    Reyes O; Torrens I; Ojalvo AG; Seralena A; Garay HE
    Mol Divers; 2004; 8(3):251-6. PubMed ID: 15384418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction.
    Taylor R; Fatovich D; Hitchcock T; Morrison C; Curtis L
    Clin Sci (Lond); 2001 Jun; 100(6):601-7. PubMed ID: 11352774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction.
    Fears R; Hearn J; Standring R; Anderson JL; Marder VJ
    Am Heart J; 1992 Aug; 124(2):305-14. PubMed ID: 1636574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.